At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
New Lymphoma Rx Approved
The US Food and Drug Administration (FDA) has approved a medication to treat adults with mantle cell lymphoma.
Second US Gene Therapy Approved
The US Food and Drug Administration (FDA) has approved the United States' second gene therapy to treat certain types of lymphoma.
New Lymphoma Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new treatment for a type of non-Hodgkin lymphoma.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has approved a new treatment for Hodgkin lymphoma.
Quality of Life May Raise Quantity of Life With Lymphoma
Feeling good about life may make it last a little longer. Lymphoma patients with high quality of life may live longer than those with lower life satisfaction.
Eric Berry Diagnosed With Hodgkin Lymphoma
Kansas City Chiefs safety Eric Berry has been diagnosed with Hodgkin lymphoma. Fortunately, his medical team has an optimistic outlook.
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
Hodgkin Lymphoma Treatment May Boost Breast Cancer Risks
The vast majority of children who develop Hodgkin lymphoma beat the blood cancer after treatment, which includes powerful radiation. A new study looked at how that therapy affected young patients later in life.
Rx May Offer Hope for Some Non-Hodgkin Lymphoma Patients
Most patients with a slow-growing form of non-Hodgkin lymphoma respond well to therapy at first. But the disease can return and become resistant to therapy. A new medication may change this pattern.
Non-Hodgkin Lymphoma Rx Reduced Tumors
A new type of medication that disables lymphoma tumor cells has shown considerable success for patients who were not responding to other treatments.